PATRICIA CLARK: Open Payments
NPI 1427052752 · BENBROOK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 55 payments from 17 companies in 2025. Trend: 2023 $1,314 · 2024 $1,300 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $201 |
| Lilly USA, LLC | 9 | $154 |
| Astellas Pharma US Inc | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $108 |
| Novo Nordisk Inc | 5 | $89 |
| GlaxoSmithKline, LLC. | 2 | $63 |
| Abbott Laboratories | 2 | $44 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| PFIZER INC. | 2 | $30 |
Products named: JARDIANCE, Veozah, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, FREESTYLE LIBRE, NEXLETOL.
Industry payments across TX — which companies pay providers there.
